Ovid therapeutics Inc

2026. g. 1. sept. 20:09 UTC

Ovid Therapeutics Inc is higher today, recovering from an early dip amid broader market dynamics and rising oil prices fueling inflation concerns.

2026. g. 31. aug. 23:01 UTC

Ovid Therapeutics Inc shares are higher in after-market trading, moving from a low of 0.19% to a high of 4.69%.

2026. g. 28. aug. 20:07 UTC

Ovid Therapeutics Inc shares are lower today amid rising U.S. Treasury yields and broader market declines. The stock saw notable volatility earlier in the session.

2026. g. 24. aug. 19:16 UTC

Ovid Therapeutics Inc shares are higher today, recovering from an earlier dip. The stock remains above its 20-day moving average and last month's price.

2026. g. 21. aug. 19:46 UTC

Ovid Therapeutics Inc is trading higher, maintaining a position near its one-month range. Shares pulled back earlier in the session but are advancing overall.

2026. g. 20. aug. 23:31 UTC

Ovid Therapeutics Inc shares are higher in after-market trading, reflecting a significant shift in momentum since Thursday's close. No specific news was identified.

2026. g. 19. aug. 21:21 UTC

Ovid Therapeutics shares declined in after-market trading, finishing near the day's low after peaking earlier in the session. The stock remains above its 20-day moving average.

2026. g. 14. aug. 19:53 UTC

Ovid Therapeutics Inc shares are higher as the company advances its clinical pipeline, with key data releases planned through 2026, attracting positive market sentiment.

2026. g. 13. aug. 19:16 UTC

Ovid Therapeutics reported Q2 EPS of -$0.08, surpassing estimates. Shares are trading higher as the company advances its clinical pipeline and maintains $169.8 million in cash.

2026. g. 12. aug. 19:46 UTC

Ovid Therapeutics Inc shares are higher, supported by positive sentiment from a recent inflation report, despite earlier declines in the session.

2026. g. 7. aug. 19:26 UTC

Ovid Therapeutics Inc shares are lower today amid broader market dynamics. The stock briefly peaked earlier in the session before declining.

2026. g. 6. aug. 22:51 UTC

Ovid Therapeutics Inc. shares are lower in after-market trading, declining since Thursday's close despite remaining above its 20-day moving average.

2026. g. 5. aug. 21:03 UTC

Ovid Therapeutics Inc shares are higher in after-market hours, continuing a positive trend from four consecutive days of gains. No specific news was identified.

2026. g. 4. aug. 23:01 UTC

Ovid Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline since Tuesday's close.

2026. g. 3. aug. 19:11 UTC

Ovid Therapeutics shares are higher as Oppenheimer raises the price target to $9.00 from $7.00, maintaining an Outperform rating.

2026. g. 31. jūl. 20:02 UTC

Ovid Therapeutics Inc shares are lower today amid rising Treasury yields and crude oil prices, contributing to broader inflation concerns affecting the biotechnology sector.

2026. g. 27. jūl. 20:07 UTC

Ovid Therapeutics Inc shares are higher during Monday's session, following a cumulative gain since Friday. The stock pulled back from earlier session highs.

2026. g. 22. jūl. 18:46 UTC

Ovid Therapeutics Inc shares are lower amid broader market volatility linked to rising crude oil prices and geopolitical tensions, with no specific news identified.

2026. g. 20. jūl. 19:36 UTC

Ovid Therapeutics Inc shares are lower today, continuing a trend of declines amid broader market pressure from geopolitical tensions and rising oil prices.